Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer

被引:32
|
作者
Yu, Hongwei [1 ]
Meng, Xianqi [2 ]
Chen, Huang [3 ]
Han, Xiaowei [1 ,4 ,5 ]
Fan, Jingfan [2 ]
Gao, Wenwen [1 ]
Du, Lei [1 ,4 ,5 ]
Chen, Yue [1 ]
Wang, Yige [1 ]
Liu, Xiuxiu [1 ]
Zhang, Lu [6 ]
Ma, Guolin [1 ]
Yang, Jian [2 ]
机构
[1] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China
[2] Beijing Inst Technol, Sch Opt & Photon, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[5] Peking Union Med Coll, Beijing, Peoples R China
[6] Shangluo Cent Hosp, Dept Sci & Educ, Shangluo, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
breast cancer; triple-negative breast cancer; tumor-infiltrating lymphocytes; mammogram; radiomics; MRI; CHEMOTHERAPY; STAGE; KI-67;
D O I
10.3389/fonc.2020.00412
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Tumor-infiltrating lymphocytes (TILs) have been identified as a significant prognostic indicator of response to neoadjuvant therapy and immunotherapy for triple-negative breast cancer (TNBC) patients. Herein, we aim to assess the association between TIL levels and mammographic features in TNBC patients. Methods: Forty-three patients with surgically proven TNBC who underwent preoperative mammography from January 2018 to December 2018 were recruited. Pyradiomics software was used to extract 204 quantitative radiomics features, including morphologic, grayscale, and textural features, from the segmented lesion areas. The correlation between radiological characteristics and TIL levels was evaluated by screening the most statistically significant radiological features using Mann-Whitney U-test and Pearson correlation coefficient. The patients were divided into two groups based on tumor TIL levels: patients with TIL levels U-test and Pearson correlation coefficient were used to analyze the statistical significance and Pearson correlation coefficient of clinical pathological features, age, and radiological features. Results: Of 43 patients, 32 (74.4%) had low TIL levels and 11 (25.6%) had high TIL levels. The histological grade of the low TIL group was higher than that of the high TIL group (p = 0.043). The high TIL group had a more negative threshold Ki-67 level (<14%) than the low TIL group (p = 0.017). The six most important radiomics features [uniformity, variance, grayscale symbiosis matrix (GLCM) correlation, GLCM autocorrelation, gray level difference matrix (GLDM) low gray level emphasis, and neighborhood gray-tone difference matrix (NGTDM) contrast], representing qualitative mammographic image characteristics, were statistically different (p < 0.05) among the low and high TIL groups. Tumors in the high TIL group had a more non-uniform density and a smoother gradient of the tumor pattern than the low TIL group. The changes in Ki-67, age, epidermal growth factor receptor, radiomic characteristics, and Pearson correlation coefficient were statistically significant (p < 0.05). Conclusion: Mammography features not only distinguish high and low TIL levels in TNBC patients but also can act as imaging biomarkers to enhance diagnosis and the response of patients to neoadjuvant therapies and immunotherapies.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
    Ezzeldin M. Ibrahim
    Meteb E. Al-Foheidi
    Mubarak M. Al-Mansour
    Ghieth A. Kazkaz
    Breast Cancer Research and Treatment, 2014, 148 : 467 - 476
  • [42] LAG-3+ tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
    Hu, Guoming
    Wang, Shimin
    Wang, Songxiang
    Ding, Qiannan
    Huang, Liming
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [43] Predicting the level of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: Usefulness of breast MRI computer-aided detection and diagnosis
    Ku, You Jin
    Kim, Hak Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Chae, Eun Young
    Choi, Woo Jung
    Lee, Hee Jin
    Gong, Gyungyub
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (03) : 760 - 766
  • [44] Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer Update for 2020
    Brown, Lauren C.
    Salgado, Roberto
    Luen, Stephen J.
    Savas, Peter
    Loi, Sherene
    CANCER JOURNAL, 2021, 27 (01): : 25 - 31
  • [45] Computational scoring of tumor infiltrating lymphocytes in triple-negative breast cancer
    Amgad, M.
    Sarkar, A.
    Srinivas, C.
    Redman, R.
    Ratra, S.
    Bechert, C. J.
    Calhoun, B. C.
    Mrazeck, K.
    Kurkure, U.
    Cooper, L. A.
    Barnes, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [46] Simple assessment reveals the importance of distribution and density of tumor-infiltrating lymphocytes in triple-negative breast cancer
    Hida, A. I.
    Mizuno, Y.
    Ueda, N.
    Oshiro, Y.
    Sugita, A.
    Matsukage, S.
    Maeda, T.
    Kito, K.
    Ohtsuki, Y.
    Aogi, K.
    BREAST, 2017, 32 : S33 - S34
  • [47] The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
    Li, Ruonan
    Cao, Lili
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Gao, Guoxuan
    Wang, Zihan
    Qu, Xiang
    Zhang, Zhongtao
    BMC CANCER, 2020, 20 (01)
  • [49] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Guoxuan Gao
    Zihan Wang
    Xiang Qu
    Zhongtao Zhang
    BMC Cancer, 20
  • [50] Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
    Garcia-Teijido, Paula
    Luque Cabal, Maria
    Pelaez Fernandez, Ignacio
    Fernandez Perez, Yolanda
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 31 - 39